Eli Lilly and Co (NYSE:LLY)

106.33
Delayed Data
As of Sep 21
 +0.26 / +0.25%
Today’s Change
73.69
Today|||52-Week Range
107.84
+25.89%
Year-to-Date
Market Rallies Despite Trade Worries: 5 Blue-Chip Picks
Sep 21 / Zacks.com - Paid Partner Content
Does Ajovy's Approval Make Teva a Pain-Free Stock to Buy?
Sep 18 / MotleyFool.com - Paid Partner Content
Eli Lilly Prices Animal Health Unit IPO at $24 Per Share
Sep 20 / Zacks.com - Paid Partner Content
Is Galapagos NV a Buy Now?
Sep 18 / MotleyFool.com - Paid Partner Content
J&J Files NDA for Erdafitinib in Urothelial Cancer Indication
Sep 19 / Zacks.com - Paid Partner Content
Glaxo Seeks EU Approval for Two-Drug Regimen in First-Line HIV
Sep 17 / Zacks.com - Paid Partner Content
Novo Nordisk to Restructure R&D Unit & Lay Off 400 Staff
Sep 19 / Zacks.com - Paid Partner Content
Teva's (TEVA) Migraine Drug Ajovy Receives FDA Approval
Sep 17 / Zacks.com - Paid Partner Content
Bayer (BAYRY) Focuses on Acquisitions, Competition a Concern
Sep 18 / Zacks.com - Paid Partner Content
Allergan Frown Lines Study Passes Test on Higher Botox Dose
Sep 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close106.07
Today’s open106.23
Day’s range105.35 - 106.87
Volume5,333,680
Average volume (3 months)3,589,063
Market cap$114.2B
Data as of 4:02pm ET, 09/21/2018

Growth & Valuation

Earnings growth (last year)-107.36%
Earnings growth (this year)+27.84%
Earnings growth (next 5 years)+14.10%
Revenue growth (last year)+7.77%
P/E ratioNM
Price/Sales3.88
Price/Book10.09

Competitors

 Today’s
change
Today’s
% change
SNYSanofi-0.60-1.36%
ABTAbbott Laboratories+0.26+0.38%
BMYBristol-Myers Squibb+0.50+0.81%
GSKGlaxoSmithKline+0.43+1.08%
Data as of 4:05pm ET, 09/21/2018

Financials

Next reporting dateOctober 23, 2018
EPS forecast (this quarter)$1.35
Annual revenue (last year)$22.9B
Annual profit (last year)-$204.1M
Net profit margin-0.89%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
David A. Ricks
Senior VP-Biotechnology &
Autoimmunity Research
Thomas F. Bumol
Corporate headquarters
Indianapolis, Indiana

Forecasts